SIC
ABBV icon

Salem Investment Counselors’s AbbVie ABBV Stock Holding History

Salem Investment Counselors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3M Buy
132,322
+427
+0.3% +$91.9K 0.83% 25
2026
Q1 		$28.7M Buy
131,895
+288
+0.2% +$63.9K 0.84% 24
2025
Q4 		$30.1M Sell
131,607
-1,147
-0.9% -$261K 0.85% 24
2025
Q3 		$30.7M Buy
132,754
+1,295
+1% +$264K 0.88% 24
2025
Q2 		$24.4M Buy
131,459
+613
+0.5% +$114K 0.77% 25
2025
Q1 		$27.4M Sell
130,846
-1,407
-1% -$274K 0.95% 22
2024
Q4 		$23.5M Buy
132,253
+1,231
+0.9% +$226K 0.77% 26
2024
Q3 		$25.9M Buy
131,022
+247
+0.2% +$46.1K 0.78% 27
2024
Q2 		$22.4M Buy
130,775
+3,813
+3% +$632K 0.72% 28
2024
Q1 		$23.1M Buy
126,962
+749
+0.6% +$129K 0.76% 25
2023
Q4 		$19.6M Buy
126,213
+2,122
+2% +$309K 0.67% 24
2023
Q3 		$18.5M Buy
124,091
+505
+0.4% +$74.1K 0.7% 22
2023
Q2 		$16.7M Sell
123,586
-760
-0.6% -$111K 0.6% 26
2023
Q1 		$19.8M Buy
124,346
+7,494
+6% +$1.15M 0.79% 21
2022
Q4 		$18.9M Buy
116,852
+1,628
+1% +$250K 0.81% 22
2022
Q3 		$15.5M Sell
115,224
-339
-0.3% -$48.6K 0.7% 26
2022
Q2 		$17.7M Sell
115,563
-6,655
-5% -$1.02M 0.81% 23
2022
Q1 		$19.8M Sell
122,218
-16,770
-12% -$2.44M 0.78% 22
2021
Q4 		$18.8M Buy
138,988
+6,411
+5% +$757K 0.66% 24
2021
Q3 		$14.3M Buy
132,577
+2,492
+2% +$285K 0.78% 32
2021
Q2 		$14.7M Buy
130,085
+14,677
+13% +$1.65M 0.81% 30
2021
Q1 		$12.5M Buy
115,408
+2,014
+2% +$215K 0.76% 32
2020
Q4 		$12.2M Buy
113,394
+4,613
+4% +$443K 0.8% 33
2020
Q3 		$9.53M Buy
108,781
+26,218
+32% +$2.47M 0.73% 34
2020
Q2 		$8.11M Buy
82,563
+336
+0.4% +$29.6K 0.69% 37
2020
Q1 		$6.26M Buy
82,227
+1,602
+2% +$136K 0.65% 39
2019
Q4 		$7.14M Sell
80,625
-433
-0.5% -$35.9K 0.59% 44
2019
Q3 		$6.14M Buy
81,058
+353
+0.4% +$24.2K 0.57% 47
2019
Q2 		$5.87M Buy
80,705
+3,861
+5% +$303K 0.54% 49
2019
Q1 		$7.27M Sell
76,844
-4,707
-6% -$385K 0.74% 31
2018
Q4 		$7.52M Buy
81,551
+4,707
+6% +$414K 0.95% 27
2018
Q3 		$7.27M Sell
76,844
-8,013
-9% -$760K 0.74% 31
2018
Q2 		$7.86M Sell
84,857
-5,253
-6% -$513K 0.72% 30
2018
Q1 		$8.31M Sell
90,110
-1,582
-2% -$174K 0.94% 30
2017
Q4 		$8.87M Sell
91,692
-6,278
-6% -$592K 0.96% 28
2017
Q3 		$8.77M Buy
97,970
+5,196
+6% +$396K 1.02% 27
2017
Q2 		$6.73M Sell
92,774
-2,427
-3% -$163K 0.78% 35
2017
Q1 		$6.2M Sell
95,201
-5,000
-5% -$314K 0.66% 41
2016
Q4 		$6.28M Buy
100,201
+1,460
+1% +$89.1K 0.72% 40
2016
Q3 		$62.3K Sell
98,741
-2,400
-2% -$155K 0.81% 37
2016
Q2 		$6.26M Buy
101,141
+569
+0.6% +$34.7K 0.75% 42
2016
Q1 		$5.75M Sell
100,572
-32,090
-24% -$1.79M 0.71% 43
2015
Q4 		$7.86M Buy
132,662
+600
+0.5% +$34.6K 0.99% 34
2015
Q3 		$7.12M Sell
132,062
-900
-0.7% -$58.6K 0.93% 33
2015
Q2 		$8.93M Buy
132,962
+1,425
+1% +$93K 1.09% 28
2015
Q1 		$7.7M Buy
131,537
+15,575
+13% +$941K 0.92% 32
2014
Q4 		$7.59M Sell
115,962
-41
-0% -$2.58K 0.9% 35
2014
Q3 		$6.7M Buy
116,003
+200
+0.2% +$11.1K 0.8% 41
2014
Q2 		$6.54M Sell
115,803
-10,545
-8% -$553K 0.79% 39
2014
Q1 		$6.49M Buy
126,348
+2,840
+2% +$144K 0.8% 43
2013
Q4 		$6.52M Buy
123,508
+5,100
+4% +$251K 0.85% 38
2013
Q3 		$5.3M Buy
118,408
+2,225
+2% +$98.6K 0.74% 45
2013
Q2 		$4.8M Buy
+116,183
New +$5.08M 0.7% 48

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Salem Investment Counselors's ABBV Position: Q2 2026 in Review

Salem Investment Counselors increased its AbbVie (ABBV) stake by 0.32% in Q2 2026, buying an estimated $91.9K and bringing the position to 132,322 shares worth $33.3M. The position accounts for 0.83% of the portfolio, ranked #25.

Salem Investment Counselors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Salem Investment Counselors held 132,322 shares of AbbVie worth $33.3M as of Q2 2026.
  • Salem Investment Counselors bought 427 AbbVie shares in Q2 2026, an estimated $91.9K.
  • AbbVie made up 0.83% of Salem Investment Counselors's portfolio in Q2 2026, its #25 holding.
  • Salem Investment Counselors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.